Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. (Q51778319)

12 April 2018

title

Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. (English)

1 reference

12 April 2018

main subject

radiation therapy

0 references

phase I clinical trial

0 references

3

Susan M Perkins

1 reference

12 April 2018

author name string

Higinia R Cárdenes

1

1 reference

12 April 2018

Tracy R Price

2

1 reference

12 April 2018

Mary Maluccio

4

1 reference

12 April 2018

P Kwo

5

1 reference

12 April 2018

T E Breen

6

1 reference

12 April 2018

Mark A Henderson

7

1 reference

12 April 2018

Tracey E Schefter

8

1 reference

12 April 2018

Kathy Tudor

9

1 reference

12 April 2018

Jill Deluca

10

1 reference

12 April 2018

Peter A S Johnstone

11

1 reference

12 April 2018

publication date

1 March 2010

1 reference

12 April 2018

Clinical and Translational Oncology

published in

1 reference

12 April 2018

volume

12

1 reference

12 April 2018

issue

3

1 reference

12 April 2018

page(s)

218-225

1 reference

12 April 2018

https://scigraph.springernature.com/pub.10.1007/s12094-010-0492-x

exact match

0 references

cites work

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0492-X

Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0492-X

Dose-response relationship in local radiotherapy for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0492-X

Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0492-X

Analysis of radiation-induced liver disease using the Lyman NTCP model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0492-X

Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0492-X

Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-010-0492-X

The use of 3-D dose volume analysis to predict radiation hepatitis

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12094-010-0492-X

21 January 2018

12 December 2020

Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients

1 reference

12 December 2020

Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Stereotactic radiotherapy of primary liver cancer and hepatic metastases

1 reference

12 December 2020

Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.

1 reference

12 December 2020

Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies

1 reference

12 December 2020

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

1 reference

12 December 2020

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

1 reference

12 December 2020

Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.

1 reference

12 December 2020

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

12 December 2020

The Effect of Multiple Small Doses of X Rays on Skin Reactions in the Mouse and a Basic Interpretation

1 reference

12 December 2020

Complication probability as assessed from dose-volume histograms.

1 reference

12 December 2020

Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization

1 reference

12 December 2020

Transection of the oesophagus for bleeding oesophageal varices

1 reference

12 December 2020

Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects

1 reference

12 December 2020

Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial.

1 reference

12 December 2020

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

12 December 2020

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

12 December 2020

Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

Management of hepatocellular carcinoma

1 reference

12 December 2020

194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study

1 reference

12 December 2020

10.1007/S12094-010-0492-X

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

20231127

1 reference

12 April 2018